Aeterna Zentaris (NASDAQ:AEZS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research note published on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $28.00 price objective on shares of Aeterna Zentaris in a research note on […]